FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128049807> ?p ?o ?g. }

• W3128049807 endingPage "582" @default.
• W3128049807 startingPage "582" @default.
• W3128049807 abstract "Among the various types of breast cancer, the luminal B subtype is the most common in young women, and ESR1-CCDC170 (E:C) fusion is the most frequent oncogenic fusion driver of the luminal B subtype. Nevertheless, treatments targeting E:C fusion has not been well established yet. Hence, the aim of this study is to investigate potential therapies targeting E:C fusion based on systematic bioinformatical analysis of the Cancer Genome Atlas (TCGA) data. One thousand related genes were extracted using transcriptome analysis, and major signaling pathways associated with breast cancer were identified with over-representation analysis. Then, we conducted drug-target network analysis based on the OncoKB and CIViC databases, and finally selected potentially applicable drug candidates. Six major cancer-related signaling pathways (p53, ATR/ATM, FOXM1, hedgehog, cell cycle, and Aurora B) were significantly altered in E:C fusion-positive cases of breast cancer. Further investigation revealed that nine genes (AURKB, HDAC2, PLK1, CENPA, CHEK1, CHEK2, RB1, CCNA2, and MDM2) in coordination with E:C fusion were found to be common denominators in three or more of these pathways, thereby making them promising gene biomarkers for target therapy. Among the 21 putative actionable drugs inferred by drug-target network analysis, palbociclib, alpelisib, ribociclib, dexamethasone, checkpoint kinase inhibitor AXD 7762, irinotecan, milademetan tosylate, R05045337, cisplatin, prexasertib, and olaparib were considered promising drug candidates targeting genes involved in at least two E:C fusion-related pathways." @default.
• W3128049807 created "2021-02-15" @default.
• W3128049807 creator A5009091190 @default.
• W3128049807 creator A5017681892 @default.
• W3128049807 creator A5023908455 @default.
• W3128049807 creator A5038980483 @default.
• W3128049807 creator A5060940016 @default.
• W3128049807 date "2021-02-04" @default.
• W3128049807 modified "2023-10-18" @default.
• W3128049807 title "Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion" @default.
• W3128049807 cites W1967997862 @default.
• W3128049807 cites W1989277387 @default.
• W3128049807 cites W1992533338 @default.
• W3128049807 cites W2004620524 @default.
• W3128049807 cites W2012614526 @default.
• W3128049807 cites W2012718299 @default.
• W3128049807 cites W2025784247 @default.
• W3128049807 cites W2040538477 @default.
• W3128049807 cites W2042337609 @default.
• W3128049807 cites W2065658468 @default.
• W3128049807 cites W2073674325 @default.
• W3128049807 cites W2096766502 @default.
• W3128049807 cites W2119145839 @default.
• W3128049807 cites W2126997165 @default.
• W3128049807 cites W2156609642 @default.
• W3128049807 cites W2171599819 @default.
• W3128049807 cites W2467112370 @default.
• W3128049807 cites W2559588208 @default.
• W3128049807 cites W2743649404 @default.
• W3128049807 cites W2771397989 @default.
• W3128049807 cites W2773461708 @default.
• W3128049807 cites W2781370437 @default.
• W3128049807 cites W2791852612 @default.
• W3128049807 cites W2794280643 @default.
• W3128049807 cites W2889646458 @default.
• W3128049807 cites W2899227888 @default.
• W3128049807 cites W2912993657 @default.
• W3128049807 cites W2944068509 @default.
• W3128049807 cites W3048242943 @default.
• W3128049807 cites W779403461 @default.
• W3128049807 doi "https://doi.org/10.3390/jcm10040582" @default.
• W3128049807 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7913953" @default.
• W3128049807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33557149" @default.
• W3128049807 hasPublicationYear "2021" @default.
• W3128049807 type Work @default.
• W3128049807 sameAs 3128049807 @default.
• W3128049807 citedByCount "7" @default.
• W3128049807 countsByYear W31280498072021 @default.
• W3128049807 countsByYear W31280498072022 @default.
• W3128049807 countsByYear W31280498072023 @default.
• W3128049807 crossrefType "journal-article" @default.
• W3128049807 hasAuthorship W3128049807A5009091190 @default.
• W3128049807 hasAuthorship W3128049807A5017681892 @default.
• W3128049807 hasAuthorship W3128049807A5023908455 @default.
• W3128049807 hasAuthorship W3128049807A5038980483 @default.
• W3128049807 hasAuthorship W3128049807A5060940016 @default.
• W3128049807 hasBestOaLocation W31280498071 @default.
• W3128049807 hasConcept C104317684 @default.
• W3128049807 hasConcept C111829193 @default.
• W3128049807 hasConcept C120504264 @default.
• W3128049807 hasConcept C121608353 @default.
• W3128049807 hasConcept C126322002 @default.
• W3128049807 hasConcept C13514818 @default.
• W3128049807 hasConcept C143998085 @default.
• W3128049807 hasConcept C150194340 @default.
• W3128049807 hasConcept C162317418 @default.
• W3128049807 hasConcept C182979987 @default.
• W3128049807 hasConcept C2775930923 @default.
• W3128049807 hasConcept C2776071976 @default.
• W3128049807 hasConcept C2779744173 @default.
• W3128049807 hasConcept C2779962180 @default.
• W3128049807 hasConcept C2781252693 @default.
• W3128049807 hasConcept C29537977 @default.
• W3128049807 hasConcept C501734568 @default.
• W3128049807 hasConcept C502942594 @default.
• W3128049807 hasConcept C530470458 @default.
• W3128049807 hasConcept C54355233 @default.
• W3128049807 hasConcept C60644358 @default.
• W3128049807 hasConcept C70721500 @default.
• W3128049807 hasConcept C71924100 @default.
• W3128049807 hasConcept C82381507 @default.
• W3128049807 hasConcept C86803240 @default.
• W3128049807 hasConceptScore W3128049807C104317684 @default.
• W3128049807 hasConceptScore W3128049807C111829193 @default.
• W3128049807 hasConceptScore W3128049807C120504264 @default.
• W3128049807 hasConceptScore W3128049807C121608353 @default.
• W3128049807 hasConceptScore W3128049807C126322002 @default.
• W3128049807 hasConceptScore W3128049807C13514818 @default.
• W3128049807 hasConceptScore W3128049807C143998085 @default.
• W3128049807 hasConceptScore W3128049807C150194340 @default.
• W3128049807 hasConceptScore W3128049807C162317418 @default.
• W3128049807 hasConceptScore W3128049807C182979987 @default.
• W3128049807 hasConceptScore W3128049807C2775930923 @default.
• W3128049807 hasConceptScore W3128049807C2776071976 @default.
• W3128049807 hasConceptScore W3128049807C2779744173 @default.
• W3128049807 hasConceptScore W3128049807C2779962180 @default.
• W3128049807 hasConceptScore W3128049807C2781252693 @default.
• W3128049807 hasConceptScore W3128049807C29537977 @default.

• next